Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study
Abstract Introduction β-Blockers are a heterogenous class of drugs that are no longer recommended for initial antihypertension monotherapy due to unfavorable long-term cardiovascular events observed with non-vasodilatory β-blockers. However, the comparative cardiovascular event risk between the vaso...
Main Authors: | Jan Basile, Brent Egan, Henry Punzi, Sanjida Ali, Qian Li, Mehul Patel, Joel Neutel |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2018-09-01
|
Series: | Cardiology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s40119-018-0117-y |
Similar Items
-
Beneficial Effects of Nebivolol in Comparison with Atenolol on Safety and Tolerability in Essential Hypertension
by: Vivek V. Bhosale, et al.
Published: (2014-06-01) -
Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients
by: Mantasha Tabassum, et al.
Published: (2024-03-01) -
THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015-09-01) -
Genome‐Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β‐Blockers
by: Mohamed H. Shahin, et al.
Published: (2018-03-01) -
β1-blockers lower norepinephrine release by inhibiting presynaptic, facilitating β1-adrenoceptors in normotensive and hypertensive rats
by: Torill eBerg
Published: (2014-04-01)